FDA Cracks Down on Telehealth Firms for 'Misleading' Weight‑Loss Drug Claims
The FDA has issued over 100 warning letters to drug makers and online health firms, including Hims & Hers, for promoting compounded versions of popular GLP‑1's.
More Videos
The Future of Farming: InnerPlant CEO on Smart Crops That Emit Optical Signals
InnerPlant CEO Shely Aronov reveals how engineered crops like soybeans and corn emit signals when stressed—offering farmers early warnings to boost yields.
How $100K H1B Visas Could Reshape Hiring
Payoneer CEO John Caplan discusses the implications of $100K H1B visa requirements—and how they could reshape tech talent, hiring, and U.S. competitiveness.
Inside the Fed’s Numbers: Sarah Foster on U.S. Economic Momentum
Bankrate’s Sarah Foster breaks down Q2's 3.8% U.S. GDP growth and what it signals in light of recent Fed data and broader economic trends.
Go Fund Yourself: A New Way of Living
Torques Games is a new way to have fun outside, while mental health app Zulni offers tools for journaling, calming moods, and connection.
Russia Put A €100k Bounty On This Autonomous War Machine in Ukraine
Meet the autonomous tanks defending Ukraine's front lines and discover why Putin is now fighting to get a hold of one.
No Monologue, No Clicks: How Host Firings Disrupt Ad Revenue and Network Balance Sheets
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
